Search results for “Skin Squamous Cell Carcinoma” companies
Free sign up to view the full data
Key Players
Order by:
Innovation Intensity
With the analysis among 59 patents, we discovered top 10 key players by total patent application. Regeneron Pharmaceuticals, Inc., Castle Biosciences, Inc., Replimune Ltd. are dominant in this area. They take 79.66% of the total patent filing.
Regeneron Pharmaceuticals, Inc.
New York, United States
Patent: 30
Castle Biosciences, Inc.
Texas, United States
Patent: 14
Replimune Ltd.
United Kingdom
Patent: 3
Shanghai Biowindow Gene Development Co. Ltd.
Shanghai Shi, China
Patent: 2
Novartis AG
Basel-Stadt, Switzerland
Patent: 1
Fuzhou Maixin Biotech Co., Ltd.
Fujian Sheng, China
Patent: 1
Fujian Chun Lun Tea Group Co. Ltd.
Fujian Sheng, China
Patent: 1
Global Health Solutions, LLC
United States
Patent: 1
Guangxi Wuzhou Pharmaceutical (Group) Co. Ltd.
Guangxi Zhuangzu Zizhiqu, China
Patent: 1
Qingdao Hyperic Biotechnology Co., Ltd.
Shandong Sheng, China
Patent: 1
Startups & Unicorns
Order by:
Innovation Intensity
No data, please try another search term
Fast-Growing
Order by:
Innovation in recent 5 years
With the analysis among related 50 patents applied in the last 5 years. We discover 15 most active companies in this area. The fast-growing Regeneron Pharmaceuticals, Inc., Castle Biosciences, Inc., Replimune Ltd. take 66.00% of patent filing during this period.
Regeneron Pharmaceuticals, Inc.
New York, United States
Patent: 16
Castle Biosciences, Inc.
Texas, United States
Patent: 14
Replimune Ltd.
United Kingdom
Patent: 3
Soochow University
Jiangsu Sheng, China
Patent: 2
Shanghai Institutes for Biological Sciences CAS
Shanghai Shi, China
Patent: 1
Xi'an Jiaotong University
Shaanxi Sheng, China
Patent: 1
Affiliated Hospital of Nantong University
Jiangsu Sheng, China
Patent: 1
Shanghai Changzheng Hospital
Shanghai Shi, China
Patent: 1
Southern Medical University
Guangdong Sheng, China
Patent: 1
Fudan University
Shanghai Shi, China
Patent: 1
New Entrants
Order by:
Innovation in recent 5 years
With the analysis among related 50 patents in last 5 years, we discover 12 new entrants. Castle Biosciences, Inc., Replimune Ltd., Soochow University are the most active new entrants in this area.
Castle Biosciences, Inc.
Texas, United States
Patent: 14
Replimune Ltd.
United Kingdom
Patent: 3
Soochow University
Jiangsu Sheng, China
Patent: 2
Shanghai Changzheng Hospital
Shanghai Shi, China
Patent: 1
Shanghai Institutes for Biological Sciences CAS
Shanghai Shi, China
Patent: 1
Xi'an Jiaotong University
Shaanxi Sheng, China
Patent: 1
Fudan University
Shanghai Shi, China
Patent: 1
Global Health Solutions, LLC
United States
Patent: 1
The Second Affiliated Hospital of Anhui Medical University
undefined undefined
Patent: 1
Affiliated Hospital of Nantong University
Jiangsu Sheng, China
Patent: 1
Research Institutions
Order by:
Innovation Intensity
With the analysis among 17 patents, we discovered top 6 universities and scientific research institutions by total patent application. Southern Medical University, Soochow University, Xi'an Jiaotong University are dominant in this area. They take 47.06% of the total patent filing.
Southern Medical University
Guangdong Sheng, China
Patent: 4
Soochow University
Jiangsu Sheng, China
Patent: 2
Xi'an Jiaotong University
Shaanxi Sheng, China
Patent: 1
Fudan University
Shanghai Shi, China
Patent: 1
University of Campinas
Goiás, Brazil
Patent: 1
Kaohsiung Medical University
China
Patent: 1
Keywords Quick Entry
Popular
Physics
Chemistry
Engineering
Materials science
Computer science
Biology
Medicine
MetalElectrodeVoltageSemiconductorPolymerElectricityCoatingFiberDisplay deviceRaw materialElectric motorUltimate tensile strengthNozzleCarbonBuilding constructionAlkylService lifeElectronOxideOxygenSolventControl unitFlangeControl systemDrugLight sourcePistonDiseaseElectric powerHigh pressure
View more
Page generation time: